Johnny Mahlangu to Europe
This is a "connection" page, showing publications Johnny Mahlangu has written about Europe.
Connection Strength
0,181
-
Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia. J Thromb Haemost. 2012 May; 10(5):773-80.
Score: 0,100
-
Haemophilia gene therapy-Update on new country initiatives. Haemophilia. 2022 May; 28 Suppl 4:61-67.
Score: 0,050
-
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A. J Thromb Haemost. 2015 Jun; 13(6):967-77.
Score: 0,031